Alyeska Investment Group’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
IA
NLVP
IVM
PVMCV
NHAS
Alyeska Investment Group's STIM Position: Q3 2018 in Review
Alyeska Investment Group sold out of Neuronetics (STIM) in Q3 2018, closing a stake of 70,000 shares — an estimated $1.86M sold.
Alyeska Investment Group first reported a position in STIM in Q2 2018 and held it in 1 quarter. The position peaked at $1.86M in Q2 2018. 74 funds tracked by Wall St. Rank hold STIM as of Q3 2018.
- Alyeska Investment Group reported no remaining Neuronetics position as of Q3 2018 after selling out during the quarter.
- Alyeska Investment Group sold 70,000 Neuronetics shares in Q3 2018, an estimated $1.86M.
- Alyeska Investment Group first reported a position in Neuronetics in Q2 2018 and held it in 1 quarter.
- Alyeska Investment Group's Neuronetics position peaked at $1.86M in Q2 2018.
- 74 funds tracked by Wall St. Rank held Neuronetics as of Q3 2018.
Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.